CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
The article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is...
Main Author: | I. S. Yavelov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2015-12-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/45 |
Similar Items
-
Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account?
by: I. S. Yavelov
Published: (2023-01-01) -
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020-06-01) -
CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN
by: Igor S. Yavelov
Published: (2018-12-01) -
СОВРЕМЕННЫЙ ПОДХОД В ЛЕЧЕНИИ ОСТРОГО ТРОМБОЗА ГЛУБОКИХ ВЕН ПРЕПАРАТОМ РИВАРОКСАБАН
by: Е. П. Кривощеко в, et al.
Published: (2015-06-01) -
Pharmacoeconomic evaluation of apixaban use for the treatment and prevention of venous thromboembolism in the general population and patients with oncological diseases
by: A. S. Kolbin, et al.
Published: (2023-03-01)